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In this study, we analyzed how distinct glycolysis inhibitors influenced the redox status of retinal
cells, used as a neuronal model. Three different approaches were used to inhibit glycolysis: the
cells were submitted to iodoacetic acid (IAA), an inhibitor of glyceraldehyde 3-phosphate dehy-
drogenase, to 2-deoxy-glucose (DG) in glucose-free medium, which was used as a substitute of
glucose, or in the absence of glucose. The redox status of the cells was evaluated by determining
the reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide). By the anal-
ysis of dose-response curves of MTT reduction, IAA showed values of IC50 = 7.02 X 10-5 M,
whereas DG showed values of IC50 = 7.42 X 10-4 M. Upon 30 min-incubation, glucose depri-
vation, per se, did not significantly affect MTT reduction. We also evaluated the reduction of MTT
as an indicator of cell injury by exposing the cells to 100 uM glutamate during the decrement of
glycolysis function. In the presence of glutamate, for 2 h, there was a decrease in MTT reduction,
which was potentiated in the presence of DG (10-20% decrease), in the presence of IAA (about
30% decrease) or in glucose-free medium (about 30% decrease). Major changes observed by the
MTT assay, upon exposure to glutamate, indicative of changes in the redox status of retinal cells,
were concomitant with variations in intracellular ATP. Under glucose deprivation, endogenous
ATP decreased significantly from 38.9 ± 4.4 to 13.3 ± 0.7 nmol/mg protein after exposure to
100 uM glutamate. The results support a different vulnerability of retinal cells after being exposed
to distinct forms of glycolysis inhibition.
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INTRODUCTION
Retinal cells, similarly to neuronal cells, are highly
dependent on the flux of oxygen and glucose (1) and
they were described to contain large sources of endog-
enous glucose and glycogen (2). Several studies have
demonstrated the importance of glycolysis in neuronal
function: K+ uptake, occurring through the Na+/K+ pump,
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was dependent on energy generated by glycolysis (3),
stimulation of glycolysis was shown to occur during the
initial phase of mitochondrial dysfunction (4) and gly-
colysis was suggested to prevent non-synaptic release of
excitatory amino acids during hypoxia (5). In the retina,
histological lesions induced by hypoglycemia-like con-
ditions were shown to be related to glutamate-induced
excitotoxicity (6). Previously, we found that hypogly-
cemia-like conditions, induced in the presence of IAA
(iodoacetic acid) or DG (2-deoxy-glucose), significantly
decreased the levels of ATP in retina co-cultures, used
Abbreviations: BME, basal medium of Eagle; DG, 2-deoxy-glucose;
IAA, iodoacetic acid; LDH, lactate dehydrogenase; MTT, 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide.
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as neuronal models, although the ATP levels after chem-
ically-induced hypoxia did not change significantly (7).
A decrement in the energy levels of the cells, even if
small, may account for the disturbance of intracellular
calcium concentration (8), which may evoke the release
of neurotransmitters. An increase in the release of ex-
citatory amino acids has been considered responsible for
the excitability of post-synaptic neurons, the accumula-
tion of free fatty acids and the production of free radi-
cals, contributing to neuronal degeneration. Glutamate
excitotoxicity was shown to be involved in the patho-
genesis of neuronal loss associated with neurological
diseases and during ischemia situations (9).
In this study, we analyzed the influence of inhibiting
glycolysis on the redox status of retinal cells, used as
neuronal models. During glycolysis inhibition, the cells
were submitted to IAA, DG or glucose deprivation. The
vulnerability of retinal cells, submitted to glutamate ex-
posure under situations that reduced glycolysis function
and then returned to glucose medium, was also evaluated.
The redox status of the cells was evaluated by the mea-
surement of two parameters, the reduction of MTT (10-
14) and the production of ATP. The data obtained may
help to determine the threshold of glycolysis inhibition
below which cell damage inevitably occurs. Metabolic in-
hibition was shown to decrease the efficacy of retinal cells
to reduce MTT, rendering the cells vulnerable during gly-
colysis dysfunction, which mediates the potentiating ef-
fects of glutamate excitotoxicity. These data may
contribute to clarify how cells respond to different energy
requirements and the extent of neuronal damage resulting
from different levels of hypoglycemia, in vivo.
EXPERIMENTAL PROCEDURE
Materials. Basal Medium of Eagle (Earle's salts- BME) was pur-
chased from Sigma (USA), trypsin from GIBCO (UK.) and fetal calf
serum from BioChrom KG (Berlin, Germany). All other chemicals
used were purchased from Sigma (USA).
Preparation of Retinal Cell Cultures. Primary cultures of retinal
cells were obtained from 8-day-old chick (White Leghorn) embryos,
as described previously (8, 15). Briefly, the retinas were dissected free
from other ocular tissues and dissociated with trypsin in a Ca2+/Mg2 -
free Hank's balanced salt solution for 15 min, at 37 °C. The digested
tissue was centrifuged and the pellet was resuspended in BME con-
taining Earle's salts and L-glutamine, buffered with 25 mM HEPES
and 10 mM NaHCO3, and supplemented with 5% fetal calf serum (heat
inactivated), penicillin (100 units/ml) and streptomycin (100 ug/ml).
After appropriate dilution, the cells were plated on Costar 12-multiwell
plates pre-coated with poly-L-lysine (0.1 mg/ml) at a density of 0.4 X
106 cell/cm2. The cells were cultured at 37 °C in an atmosphere of
95% air and 5% CO2. Similar cultures of retinal cells were previously
described to be highly enriched in amacrine neuron-like cells (16, 17).
These cultures also contain neurons resembling bipolar cells and few
glial cells (5).
Induction of Glycolysis Inhibition and Analysis of MTT Reduc-
tion. Five days after plating, the retinal cells were incubated with in-
hibitors of glycolysis to induce conditions of chemical hypoglycemia.
The culture medium was removed and the cells were pre-incubated,
for 10 min, in a sodium saline solution, containing (in mM): NaCl
140.0, KCl 5.0, CaCl2 1.5, MgCl2 1.0, NaH2PO4 1.0, glucose 5.6 and
HEPES 20.0, at pH 7.4. The inhibition of glycolysis function was
induced with IAA, which inhibits the glycolytic enzyme glyceralde-
hyde 3-phosphate dehydrogenase, with DG in glucose-free medium,
which substitutes glucose in the incubation medium and is not metab-
olized by the cells, or simply in the absence of glucose. Incubations
were carried out at 37 °C in the presence (5.6 mM) or in the absence
of glucose, for the periods of time indicated in the Figure legends.
Control cells were incubated in the absence of chemical inducers, in
the presence of glucose. When indicated, the cells were exposed to
glutamate (100 uM), in the presence or in the absence of glucose, for
2 h. Retinal cells were also submitted to glutamate after 30 min-in-
cubation in the presence of specific glycolytic inhibitors.
The efficacy of retinal cells to reduce MTT into formazan, an
insoluble product, was performed by following the method described
by Mosmann (10). Briefly, after incubation of retinal cells, the medium
was removed and MTT (final concentration 0.5 mg/ml in sodium sa-
line solution containing glucose, prepared just before using and main-
tained in the dark) was added to the cells. Incubation with MTT was
performed in sodium saline solution. After incubation for 3 h, at 37
°C, to obtain a maximal formation of formazan cristals, an equal vol-
ume of acid-isopropanol (0.04 M HC1 in isopropanol) was added and
mixed thoroughly at room temperature until all formazan crystals were
dissolved. The absorbance of the samples was measured at 570 nm,
against a blank containing the solution of MTT and acid-isopropanol.
The efficacy of retinal cells to reduce the MTT was expressed as a
percentage of OD of control cells, in the absence of glycolytic inhib-
itors or glutamate, because the number of cells was not significantly
changed after each treatment.
Intracellular ATP Measurements. Retinal cells were extracted
with 0.3 M perchloric acid after the incubation for 2 h in the absence
or in the presence of glutamate (100 uM) in cells pre-incubated (30
min) with glucose medium in the absence or in the presence of IAA
(25 uM) or without glucose. The acidic extract was centrifuged at
15800 xg, for 5 min, at 0-4 °C. The pellets were analyzed for total
protein (18), whereas the supernatants were neutralized with 10 M
KOH in 5 M Tris. After neutralization the samples were centrifuged
at 15800 xg, for 10 min, at 0-4 °C, and stored at -80 °C until HPLC
injection. The supernatants were assayed for ATP, by separation in a
reversed phase HPLC (19), eluted at a flow rate of 1.2 ml/min with
100 mM KH2PO4, pH 7.4, and 1% methanol. The nucleotides were
detected at 254 nm, for 6 min.
Data Analysis. Throughout the text, data are expressed as means
± SEM of the indicated number of experiments. The 1C50 values for
IAA and DG were determined by using the sigmoidal equation (var-
iable slope) of Graph Pad Prism. Statistical significance was deter-
mined by using the unpaired two-tailed Student's t-test and by using
the one-way ANOVA Tukey post-test for multiple comparisons. A P
value < 0.05 was considered significant.
RESULTS
Time-Course of MTT Reduction Upon Recovering
from Glycolysis Inhibition. Fig.l shows the time-depen-
7.02 X 10-5 M (-log IC50 = 4.15 ± 0.17), whereas in
the presence of DG, the IC50 was 7.42 X 10-4 M (-log
IC50 = 3.13 ± 0.10). These data indicated that specific
inhibition of glycolysis in retinal cells in culture, in the
presence of IAA or DG, highly decreased the retinal
cells efficiency to reduce MTT.
Susceptibility of Retinal Cells to Glutamate Upon
Glycolysis Inhibition. In order to investigate the impor-
tance of distinct glycolytic inhibitors in the susceptibility
of retinal cells to glutamate, we analyzed their efficacy
Fig. 2. Dose-response curves of IAA and DG on the reduction of MTT
in retinal cells.
The cells were exposed to IAA (25 X 10-6 M to 2 X 10-3 M) in the
presence of glucose (A) or to DG (100 X 1Q-6 M to 10 X 10-3 M)
in the absence of glucose (B), for 30 min, at 37 °C. MTT reduction
was determined as described under Experimental procedure. Data are
the means ± SEM of two to four experiments, each run in triplicates.
The graph curves were plotted following the equations:
y = -360.14 - 303.32x - 78.51x2 - 7.24x3 (r = 0.99) for the dose-
response curve of IAA (A), or y = 173.53 + 198.51x + 98.45x2 +
18.40x3 + 1.23x4 (r = 0.99) for the dose-response curve of DG (B).
The IC50 values were calculated by using the sigmoidal equation (var-
iable slope) of the Graph Pad Prism. Data obtained in the presence of
IAA or DG showed statistical significance (P < 0.001) as compared
to the controls (C), in the presence of glucose.
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Fig. 1. Time-dependent changes in MTT reduction induced by inhib-
itors of glycolysis function.
Retinal cells were exposed to 0.5 mM IAA in glucose medium, to 2
mM DG in the absence of glucose, to glucose-free medium, or to
medium containing glucose (5.6 mM), for 0.25, 0.5, 1, 2, 5, 15 or 30
min, at 37 Deg C, The MTT colorimetric assay was performed as de-
scribed under Experimental procedure. Data are the means ± SEM
of two to four experiments, each run in triplicates. Statistical signifi-
cance: *P < 0.01 or **P < 0.001 as compared to controls in the
presence of glucose, but in the absence of glycolytic inhibitors.
dent changes of MTT reduction in retinal cells exposed
to inducers of glycolysis inhibition, for 15 sec and up to
30 min. In the absence of glucose, there were not sig-
nificant changes in MTT reduction as compared to con-
trol conditions, in the presence of glucose. Nevertheless,
in the presence of IAA (0.5 mM) or DG (2 mM) there
was a significant decrease in MTT reduction after 15 sec
(P < 0.05) or after 1 min (P < 0.01), respectively. MTT
reduction in the presence of IAA or DG was similar after
15 or 30 min (Fig. 1). We also analyzed the influence of
glycolytic inhibitors on the release of lactate dehydro-
genase (LDH), after incubation for 5, 15 or 30 min, al-
though we could not find significant differences between
each cell treatment and the controls, in cells incubated
in the presence of glucose (not shown).
Dose-Response Curves of MTT Reduction Induced
by lodoacetic Acid or Deoxyglucose. We next studied
the dose-response curves of IAA (Fig.2-A), or DG
(Fig.2-B), incubated for 30 min, in the efficacy of retinal
cells to reduce MTT. The concentrations of IAA ranged
from 25 X 10-6 to 2 x 10-3 M, whereas the concentra-
tions of DG ranged from 100 X l0-6 to 10 X 10-3 M.
The efficiency to reduce MTT was evaluated by deter-
mining the IC50 values, the concentration of IAA or DG
providing 50% loss of MTT reducing ability by retinal
cells in culture. In the presence of IAA, the IC50 was
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Fig. 3. Influence of inhibition of glycolysis and glutamate on the reduction of MTT by retinal cells.
Retinal cells were pre-incubated for 30 min in the presence (A, B) or in the absence of glucose (C, D). Inhibition
of glycolysis was also induced in the presence of IAA (25 uM), as shown in B, or with DG (2 mM), as shown
in C or D, prior to glutamate (Glu) incubation. The cells were further exposed to 100 uM glutamate, in the
presence (A, C) or in the absence of glucose (B, D), but in the absence of IAA or DG, for 2 h. Then, they were
incubated with MTT (0.5 mg/ml) in Na+ medium containing glucose, for 3 h, as described under Experimental
procedure. Data, expressed as a percentage of MTT reduction in control retinal cells incubated in the presence of
glucose for 30 min plus 2 h (A), are the means ± SEM of duplicates or triplicates from two to eight experiments.
Statistical significance: *P < 0.01 or **P < 0.001 as compared to the respective control; +P < 0.01 as compared
to similar conditions, in the absence of glutamate.
to reduce MTT after being exposed to IAA, DG or glu-
cose-free medium, for 30 min. This period of time was
used as a pre-incubation period sufficient to induce al-
most maximal effects (Fig.l), which was followed by 2
h exposure to 100 uM glutamate, in the presence or in
the absence of glucose. In these experiments, IAA was
used at a concentration closer to the IC50 value (about
70 uM) determined in Fig. 2, so that glutamate toxicity
could be detected. The inhibition of MTT reduction ob-
served in the presence of 0.5 mM IAA, after 30 min-
incubation, was of about 60%, partly masking further
changes observed upon incubation with glutamate (not
shown). Fig. 3-A shows that glutamate alone in the pres-
ence of glucose decreases slightly, although signifi-
cantly, the reduction of MTT (88.3 ± 1.4%, P<0.001),
as compared to the control, in the absence of glutamate.
In the presence of glutamate, in cells submitted to glu-
cose deprivation for 2 h, there was a decrease in MTT
reduction to 79.9 ± 2.6% of control (Fig.3-B). MTT
data obtained in the presence of IAA (25 uM) alone,
followed by incubation in the absence of glucose, with
no IAA added, was of 78.1 ± 4.8% of control. Never-
theless, we observed a further decrement in MTT reduc-
tion when the last two treatments were applied.
Treatment of retinal cells with IAA, followed by incu-
bation with glutamate in the absence of glucose, pre-
sented values of MTT reduction of 54.7 ± 3.3% (P <
0.01, as compared to incubation with IAA in the absence
of glutamate or glutamate exposure without IAA pre-
treatment), indicating potentiating effects induced by
glutamate.
In Fig. 3-C we observed a significant, but smaller,
decrement in MTT reduction upon treatment with DG
(2 mM) in the absence of glucose, for 30 min, followed
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tions, MTT reduction was also greatly decreased (52.6
± 1.1%) and 100 uM glutamate potentiated that de-
crease (41.9 ± 2.0%), as shown in Fig. 3-D. Compari-
son of data shown in Fig. 3-C and D, in cells incubated
with DG, indicated that MTT reduction is favored by
exposure of retinal cells to glucose-containing medium.
We next examined the time-dependent changes in
MTT reduction elicited by 100 uM glutamate (Fig.4), in
cells deprived of glucose during all the experimental
procedure and exposed to glutamate, because a large de-
crease in MTT reduction was observed under these con-
ditions (Fig. 3-D, second bar). Figure 4 shows that
glutamate potentiated the increase in cell injury, as de-
termined by the reduction of MTT after incubation with
glutamate (100 uM) for 15 min (88.1 ± 2.9%, P <
0.001 as compared to the respective control.) Maximal
effects were observed after exposure of the cells to glu-
tamate for 2 h (50.7 ± 3.3% versus 89.5 ± 3.0% ob-
served in the absence of glutamate), At 4 h and up to 6
h, glutamate-mediated cell injury, evaluated by the dif-
ference between treatment in the presence and in the
absence of glutamate, was decreased, because cells sub-
mitted to glucose deprivation showed already a high sus-
ceptibility, with values reaching 63.8 ± 2.0% after 6 h
in the absence of glutamate (Fig.4). After 6 h in the
presence of glucose, glutamate potentiated cell injury at
a similar extent, when compared to conditions in the
absence of glucose (Fig.4).
Changes in Intracellular ATP Levels Induced by
Glycolytic Inhibitors and Glutamate. The analysis of the
susceptibility of retinal cells to glycolytic inhibitors and
glutamate was also performed by measuring the levels
of intracellular ATP, in order to evaluate a relationship
between loss of MTT reduction and altered metabolic
function. Incubation of retinal cells with glutamate (100
(iM) in the presence of glucose did not affect signifi-
cantly the levels of ATP, as shown in Table I. Never-
theless, incubation with glutamate in the absence of
glucose, in cells pre-incubated in glucose medium (Table
I-A), significantly decreased ATP production, from 55.5
± 3.5 nmol/mg protein in the absence to 33.0 ± 2.4
nmol/mg protein (P < 0.001) in the presence of gluta-
mate. Pre-incubation with IAA in glucose medium (Ta-
ble I-B) did not significantly influence the ATP levels
in the absence of glutamate exposure. Glutamate expo-
sure in glucose-free medium, after a pre-incubation with
IAA, significantly decreased the ATP levels to 26.9 ±
3.1 nmol/mg protein (P < 0.001). Moreover, the levels
of intracellular ATP in retinal cells incubated in the ab-
sence of glucose and glutamate (Table I-C) were signif-
icantly changed (P < 0.05) as compared to
pre-incubation with glucose. Upon 100 uM glutamate
by incubation in medium containing glucose (90.5 ±
2.2%, P < 0.01). Retinal cells incubated in the presence
of DG and exposed to glutamate in the presence of glu-
cose also showed a higher decrement in MTT reduction
(75.3 ± 2.4%, P < 0.01 as compared to incubation with
DG, in the absence of glutamate). The effect of gluta-
mate in decreasing the reduction of MTT in the presence
of glycolytic inhibitors was of about 30% in the presence
of IAA and about 10-20% in the presence of DG, a large
effect as compared to the effect mediated by these in-
hibitors when incubated separately.
We also tested the effect of incubating the retinal
cells in the absence of glucose on MTT reduction (Fig.
3-D). The incubation with glutamate (100 uM) in the
absence of glucose (2 h), in cells pre-exposed to glucose-
free medium, highly decreased the reduction of MTT to
62.4 ± 2.1% (P < 0.001 as compared to the respective
control). This inhibition was greater than that observed
when glutamate was incubated in the absence of glucose,
in cells pre-incubated in the presence of glucose. The
effect of DG was also examined by incubating the cells
in glucose-free conditions for 2 h. Under these condi-
Fig. 4. Time-dependent changes in MTT reduction induced by gluta-
mate under glucose deprivation.
Retinal cells were pre-incubated for 30 min in the absence of glucose,
similarly as performed in Fig. 3-D. Then, the cells were incubated in
the absence (white circles) or in the presence (black circles) of 100
uM glutamate in glucose-free medium, for 15 min and up to 6 h. The
cells were also incubated with glucose for 30 min plus 15 min or 6
h, in the absence (white squares) or in the presence (black squares) of
100 uM glutamate. The results, calculated as a percentage of data
observed in the presence of glucose for 30 plus 15 min (controls, not
significantly different from data observed in the absence of glucose),
are the means ± SEM of triplicates from three to four experiments.
Statistical significance: +P < 0.01, +P < 0.001 as compared to data
in the absence of glutamate; *P < 0.05, **P < 0.01 or ***P < 0.001
as compared to data obtained after 15 min, under similar experimental
conditions.
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exposure under glucose deprivation, ATP decreased sig-
nificantly to 13.31 ± 0.7 nmol/mg protein (P < 0.001,
Table I-C). These results indicated that glutamate poten-
tiated the decrement of ATP caused by glucose depri-
vation. The decrease in ATP levels induced by glutamate
in cells completely deprived of glucose was also ob-
served in the presence of 10 uM glutamate (not shown).
DISCUSSION
In the present study, we showed that retinal cells in
culture are differently vulnerable to glycolysis inhibition.
IAA or DG caused a dose-dependent decrease in MTT
reduction, showing IC50 = 7.02 X 10-5 M or IC50 =
7.42 X 10-4, respectively. These data indicated that, a
specific inhibition of the glycolytic enzyme glyceralde-
hyde 3-phosphate dehydrogenase by IAA, or the substi-
tution of DG for glucose inhibited glycolysis and highly
decreased the efficiency of retinal cells to reduce MTT
(Fig. 1 and 2). Exposure to glutamate (100 uM) during
glycolysis inhibition decreased the cellular redox status,
as observed by a decrement in MTT reduction and by a
decrease in endogenous ATP.
Although MTT reduction has been argued to be
carried out by active mitochondria (10-14, 20) we show
that reduction of MTT requires the maintenance of gly-
colysis function, because glycolytic inhibitors, IAA or
DG, induced a substantial time-dependent and dose-de-
pendent decrease in MTT reduction (Fig. 1 and 2). A
prolonged exposure to glucose deprivation, for 4 h or
more (Fig. 4), also decreased the reduction of MTT.
These results suggest the need of reducing agents, such
as NADH, generated through glycolysis at the level of
glyceraldehyde 3-phosphate dehydrogenase, to obtain a
maximal reduction of MTT. We also show that distinct
forms of glycolysis inhibition affected MTT reduction
or the cellular redox status, even when the cells are re-
incubated in medium containing glucose. NADH- or
NADPH-dependent redox systems were shown to be the
principal reductants for MTT, reflecting the redox status
of the cells (21, 22). Data in this study suggested that
MTT reduction may also represent an early indicator of
cell damage, because the decrease in metabolic function,
in the presence of glycolytic inhibitors, resulted in a sig-
nificant decrease in the redox efficacy of cultured retinal
cells. Exposure to 100 uM glutamate, for 2 h, under
glucose deprivation, increased significantly (P < 0.05)
the release of LDH (about 13% of total) after incubation
in medium containing glucose, as compared to cells in-
cubated in the absence of glutamate. Patel at al. (23)
demonstrated that the MTT test fails to give adequate
indication of astroglial cell damage induced by the am-
yloid B-protein as compared with LDH release and try-
pan blue exclusion methods. The indication of early
metabolic failure by the MTT test, rather than overall
cell damage, seems to be a good starting point to be
examined before irreversible cell damage occurs. Al-
though Liu et al (24) reported that MTT was not per-
meable to lipid membranes, and MTT reduction was
primarily confined to endosomes/liposomes in intact B12
cells, we can not exclude the possibility that different
cell types offer distinct membrane permeabilities to
MTT and that at least some of the MTT is reduced at
the level of the mitochondria. Although the extra-mito-
chondrial reduction of MTT is highly increased in rat
hepatocytes, mitochondrial dehydrogenase activity (20,
22) or cellular generation of superoxide anions may con-
stitute other (minor) sources of MTT reduction (21, 22,
25) Liu et al (24) also showed that in isolated mito-
chondria, malate plus glutamate or succinate supported
MTT reduction. Early (10, 11) and more recent (2-14,
24) studies indicated that MTT is (partly) reduced by
active mitochondria, although it can not be dissociated
from reduction by non-mitochondrial enzymes (25, 26).
By exposing the retinal cells with glutamate, we
were able to determine the influence of metabolic failure
of cells in the presence of glycolytic inhibitors, in the
extent of cell injury, as evaluated by the cellular redox
status and energy levels. Glutamate (100 uM) was
shown to potentiate cell injury in the presence of gly-
colytic inhibitors, as evaluated by a significant loss in
Table I. Effect of Reduced Glucose Metabolism on the Intracellular





























Retinal cells were pre-incubated for 30 min in the presence (A) or in
the absence of glucose (C), or in the presence of 25 uM IAA in glu-
cose medium (B). Then, the cells were exposed to 100 uM glutamate
(+ glutamate) for 2 h (post-incubation) in the absence or in the pres-
ence of glucose. Intracellular ATP (in nmol/mg protein) was analyzed
by reversed phase HPLC, after perchloric acid extraction and neutral-
ization with KOH/Tris. Data are the means ± SEM of five to seven
separate experiments. Statistical significance (ANOVA test for multi-
ple comparisons): aP < 0.001 as compared to similar experimental
conditions in the absence of glutamate (— glutamate); bP < 0.05 as
compared to pre-incubation with glucose (A), in the absence of glu-
tamate; n.d., not determined.
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MTT reduction observed in the presence IAA, DG or
under glucose deprivation (Fig.3). Major increments in
cell injury induced by 100 uM glutamate were observed
after pre-incubation with IAA (Fig.3-B) or under glu-
cose-free conditions (Fig. 3-D). A significant decrement
in MTT reduction, elicited in the presence of glycolytic
inhibitors (Fig. 3), was followed by a significant decre-
ment in intracellular ATP, by 1.6-fold (Table I), sug-
gesting that at least part of the effects observed were due
to glycolysis metabolic dysfunction.
Previously, glycolysis inhibition was shown to re-
duce the ATP levels in rat striatal slices (27) or in retinal
co-cultures from chick embryos (7). Cell toxicity asso-
ciated with hypoglycemia situations has also been re-
fered to be associated with the alteration of Ca2+
homeostasis (8, 28, 29), proposed to initiate cell damage.
The maintenance of glycolysis has been considered im-
portant in partly (8) or totally (5) preventing the non-
synaptic release of excitatory amino acids, which are ca-
pable of stimulating NMDA and non-NMDA glutamate
receptors, causing delayed neurodegeneration in the ret-
ina (30). Glycolysis inhibition with IAA was previously
shown to produce serious histological lesions in retina
from chick embryos. These lesions could be reverted
upon application of selective antagonists of glutamate
receptors, suggesting the involvement of glutamate re-
ceptors on the retina damage caused by metabolic stress.
Previously, IAA was demonstrated to cause the inhibi-
tion of sodium-dependent glutamate transporter (31).
The inhibition of the glutamate transporter was shown
to increase the neurotoxicity of glutamate by an en-
hanced accumulation of extracellular glutamate (31-35).
Glucose deprivation was also shown to enhance the re-
lease of arachidonic acid (20:4) evoked by glutamate
(34, 35) which could contribute to an increased inhibi-
tion of the glutamate transporter.
In this work, we showed that retinal cells are dif-
ferently susceptible to the various inducers of glycolysis
inhibition. Furthermore, glutamate potentiated the in-
crease in cell damage through the decrease in intracel-
lular ATP. Because the redox status of retinal cells,
recovering from glucose deprivation, was not signifi-
cantly changed up to 2 h in the absence of glucose
(Fig.4) data highly suggest a short "therapeutic win-
dow" for complete recover of neuronal cells in the pe-
numbra area after an ischemic insult.
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